pharmaceuticals

  1. Ron Strider

    Here's What Caused This Marijuana Stock To Skyrocket 15% In November

    Medical marijuana has been used to treat epilepsy in patients for years, but so far, it's efficacy and safety hasn't been supported by a regulatory green light from the Food and Drug Administration (FDA). Based on recently reported results for Epidiolex, a cannabidiol epilepsy medicine, that...
  2. Ron Strider

    AR: Medical Marijuana Symposium Brings Patients Together

    The focus Tuesday night was on the patients at a medical cannabis symposium hosted by the Arkansas Cannabis Industry Association. "Our goal as an association is to connect patients, who are suffering with medical cannabis that will help their ailments," says Storm Nolan, ACIA President...
  3. Katelyn Baker

    GW Pharmaceuticals And British Sugar Sign Cannabis Plant Deal

    British Sugar — a subsidiary of Associated British Foods — has signed a deal to grow cannabis plants for GW Pharmaceuticals. The marijuana plants — which are of a non-psychoactive variety — are for use in GW's experimental childhood epilepsy treatment called Epidiolex. The drug is derived...
  4. Katelyn Baker

    GW Pharmaceutical Gets Closer To Forcing FDA On Cannabis

    British biotech company GW Pharmaceuticals announced positive results on its latest Phase 3 clinical trial for its drug Epidiolex. The drug is cannabidiol-based and is used to treat children with Lennox-Gastaut syndrome, a rare form of childhood epilepsy. The results from the test were very...
  5. Katelyn Baker

    GW Pharmaceutical Gets Closer To Forcing FDA On Cannabis

    British biotech company GW Pharmaceuticals announced positive results on its latest Phase 3 clinical trial for its drug Epidiolex. The drug is cannabidiol-based and is used to treat children with Lennox-Gastaut syndrome, a rare form of childhood epilepsy. The results from the test were very...
  6. Katelyn Baker

    Cannabis Drug Firm GW Pharmaceuticals Taps Wall Street For $252 Million

    Wall Street's strait-laced Republican bankers may have strong personal views on the legalisation of cannabis, but they seem to have no qualms about cashing in on America's marijuana revolution. GW Pharmaceuticals, London's own play on the increasing use of weed for medicinal purposes, has...
  7. Katelyn Baker

    Cannabis Drug Firm GW Pharmaceuticals Taps Wall Street For $252 Million

    Wall Street's strait-laced Republican bankers may have strong personal views on the legalisation of cannabis, but they seem to have no qualms about cashing in on America's marijuana revolution. GW Pharmaceuticals, London's own play on the increasing use of weed for medicinal purposes, has...
  8. G

    Greetings from SE WA!

    Hi, new here. Looking for assistance for chronic pain due to Trigeminal neuralgia. Have strains of diesel in the ground, but not sure what the community would recommend. On a handful of pharmaceuticals so can't be reckless either. I am looking forward to talking with you. GG
  9. Katelyn Baker

    Marijuana-Based Drug Helps Kids With Rare Forms Of Epilepsy In Studies

    An oil derived from marijuana plants proved effective in a rare form of epilepsy that afflicts 30,000 Americans, its maker said this morning. GW Pharmaceuticals, a London-based company, is developing a drug called Epidiolex, a pharmaceutical-grade form of cannabidiol (CBD), an oil found in...
  10. Katelyn Baker

    Marijuana-Based Drug Helps Kids With Rare Forms Of Epilepsy In Studies

    An oil derived from marijuana plants proved effective in a rare form of epilepsy that afflicts 30,000 Americans, its maker said this morning. GW Pharmaceuticals, a London-based company, is developing a drug called Epidiolex, a pharmaceutical-grade form of cannabidiol (CBD), an oil found in...
  11. R

    MGC Pharmaceuticals Is Applying For A License To Grow Cannabis In Australia

    MGC Pharmaceuticals will grow cannabis in Australia as part of its plan for the medicinal cannabis market. Releasing a five-point plan for the local market, the company says it is working on applying for a growing license from relevant state departments A short time ago, its shares were up...
  12. R

    GW Pharmaceuticals Seeks FDA Approval For Cannabis Based Epidiolex

    Children afflicted with Dravet Syndrome, a rare form of epilepsy, have been effectively treated with a cannabis-based drug, Epidiolex, containing cannabinoids, the GW Pharmaceuticals announced Monday. Investors snapped up shares of the little-known firm, effectively doubling the company's market...
Back
Top Bottom